Concerns About Cancer Risk and Experiences With Genetic Testing in a Diverse Population of Patients With Breast Cancer
Authors:
- Reshma JagsiRJReshma Jagsi
- Kent A. GriffithKGKent A. Griffith
- Allison W. KurianAKAllison W. Kurian
- Monica MorrowMMMonica Morrow
- Ann S. HamiltonAHAnn S. Hamilton
- John J. GraffJGJohn J. Graff
- Steven J. KatzSKSteven J. Katz
- Sarah T. HawleySHSarah T. Hawley
- 10 May 2015
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 33 (14) , 1584-1591
Abstract
Purpose: To evaluate preferences for and experiences with genetic testing in a diverse cohort of patients with breast cancer identified through population-based registries, with attention to differences by race/ethnicity.Methods: We surveyed women diagnosed with nonmetastatic breast cancer from 2005 to 2007, as reported to the SEER registries of metropolitan Los Angeles and Detroit, about experiences with hereditary risk evaluation. Multivariable models evaluated correlates of a strong desire for genetic testing, unmet need for discussion with a health care professional, and receipt of testing.Results: Among 1,536 patients who completed the survey, 35% expressed strong desire for genetic testing, 28% reported discussing testing with a health care professional, and 19% reported test receipt. Strong desire for testing was more common in younger women, Latinas, and those with family history. Minority patients were significantly more likely to have unmet need for discussion (failure to discuss genetic testing with a health professional when they had a strong desire for testing): odds ratios of 1.68, 2.44, and 7.39 for blacks, English-speaking Latinas, and Spanish-speaking Latinas compared with whites, respectively. Worry in the long-term survivorship period was higher among those with unmet need for discussion (48.7% v 24.9%; P <.001). Patients who received genetic testing were younger, less likely to be black, and more likely to have a family cancer history.Conclusion: Many patients, especially minorities, express a strong desire for genetic testing and may benefit from discussion to clarify risks. Clinicians should discuss genetic risk even with patients they perceive to be at low risk, as this may reduce worry.Keywords
This publication has 41 references indexed in Scilit:
- Decision Involvement and Receipt of Mastectomy Among Racially and Ethnically Diverse Breast Cancer PatientsJNCI: Journal of the National Cancer Institute, 2009
- Risk perception after genetic counseling in patients with increased risk of cancerHereditary Cancer in Clinical Practice, 2009
- What women with ovarian cancer think and know about genetic testingGynecologic Oncology, 2008
- Strategies for Controlling Biases in Survey DataInternational Journal of Social Research Methodology, 2008
- Attitudes and Misconceptions about Predictive Genetic Testing for Cancer RiskPublic Health Genomics, 2005
- Too much, too soon? Patients and health professionals' views concerning the impact of genetic testing at the time of breast cancer diagnosis in women under the age of 40European Journal of Cancer Care, 2005
- Knowledge, Attitudes, and Utilization of BRCA1/2 Testing among Women with Early-Onset Breast CancerGenetic Testing, 2005
- Attitudes and distress levels in women at risk to carry a BRCA1/BRCA2 gene mutation who decline genetic testingAmerican Journal of Medical Genetics Part A, 2002
- Early use of clinical BRCA1/2 testing: Associations with race and breast cancer riskAmerican Journal of Medical Genetics Part A, 2002
- Interest in genetic testing among first‐degree relatives of breast cancer patientsAmerican Journal of Medical Genetics, 1995